"Liang L, Moore B, Soni A. National inpatient hospital costs: The most expensive conditions by payer, 2017. 2020. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); Statistical Brief #261.
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA.2016;315(8):801-810. doi:10.1001/jama.2016.0287.
Shrestha P, Cooper BS, Coast J, at al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control. 2018;7(9):1-9. doi:10.1186/s13756-018-0384-3.
Rhee C, Filbin MR, Massaro AF et al; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Compliance with the national SEP-1 quality measure and association with sepsis outcomes: A multicenter retrospective cohort study. Crit Care Med. 2018;46(10):1585-1591. doi: 10.1097/CCM.0000000000003261.
Townsend SR, Phillips GS, Duseja R, at al. Effects of compliance with the early management bundle (SEP-1) on mortality changes among Medicare beneficiaries with sepsis: A propensity score matched cohort study. Chest. 2022;161(2):392-406. doi:10.1016/j.chest.2021.07.2167.
Leisman DE, Doerfler ME, Ward MF, et al. Survival benefit and cost savings from compliance with a simplified 3-hour sepsis bundle in a series of prospective, multisite, observational cohorts.Crit Care Med.2017;45(3):395-406. doi:10.1097/CCM.0000000000002184. "
Comments
References:
"Liang L, Moore B, Soni A. National inpatient hospital costs: The most expensive conditions by payer, 2017. 2020. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); Statistical Brief #261.
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA.2016;315(8):801-810. doi:10.1001/jama.2016.0287.
Shrestha P, Cooper BS, Coast J, at al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control. 2018;7(9):1-9. doi:10.1186/s13756-018-0384-3.
Rhee C, Filbin MR, Massaro AF et al; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Compliance with the national SEP-1 quality measure and association with sepsis outcomes: A multicenter retrospective cohort study. Crit Care Med. 2018;46(10):1585-1591. doi: 10.1097/CCM.0000000000003261.
Townsend SR, Phillips GS, Duseja R, at al. Effects of compliance with the early management bundle (SEP-1) on mortality changes among Medicare beneficiaries with sepsis: A propensity score matched cohort study. Chest. 2022;161(2):392-406. doi:10.1016/j.chest.2021.07.2167.
Leisman DE, Doerfler ME, Ward MF, et al. Survival benefit and cost savings from compliance with a simplified 3-hour sepsis bundle in a series of prospective, multisite, observational cohorts.Crit Care Med.2017;45(3):395-406. doi:10.1097/CCM.0000000000002184. "